Adenovirus Lacking E1b Efficiently Induces Cytopathic Effect in HPV-16-Positive Murine Cancer Cells via Virus Replication and Apoptosis

References

• Niemann J, Kuhnel F. Oncolytic viruses: adenoviruses. Virus Genes. 2017;53(5):700–706. doi:10.1007/s11262-017-1488-1. PMID:28702840.
   PubMed Web of Science ®Google Scholar
• Robinson M, Li B, Ge Y, Ko D, Yendluri S, Harding T, VanRoey M, Spindler KR, Jooss K. Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors. J Virol. 2009;83(8):3450–62. doi:10.1128/JVI.02561-08. PMID:19193803.
   PubMed Web of Science ®Google Scholar
• Zhang L, Hedjran F, Larson C, Perez GL, Reid T. A novel immunocompetent murine model for replicating oncolytic adenoviral therapy. Cancer Gene Ther. 2015;22(1):17–22. doi:10.1038/cgt.2014.64. PMID:25525035.
   PubMed Web of Science ®Google Scholar
• Kang S, Kim JH, Kim SY, Kang D, Je S, Song JJ. Establishment of a mouse melanoma model system for the efficient infection and replication of human adenovirus type 5-based oncolytic virus. Biochem Biophys Res Commun. 2014;453(3):480–5. doi:10.1016/j.bbrc.2014.09.107. PMID:25280999.
   PubMed Web of Science ®Google Scholar
• Chen C, Fang H, Han Z, Ye F, Ji T, Gong D, Li F, Zhou J, Ma D, Gao Q. Novel permissive murine immunocompetent orthotopic colon carcinoma model for comparison of the antitumoral and safety profiles of three Adv-TKs. Gene Ther. 2014;21(11):975–83. doi:10.1038/gt.2014.79. PMID:25185643.
   PubMed Web of Science ®Google Scholar
• Cheng PH, Rao XM, Wechman SL, Li XF, McMasters KM, Zhou HS. Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice. BMC Cancer. 2015;15:716. doi:10.1186/s12885-015-1731-x. PMID:26475304.
   PubMed Web of Science ®Google Scholar
• Jiang H, Clise-Dwyer K, Ruisaard KE, Fan X, Tian W, Gumin J, Lamfers ML, Kleijn A, Lang FF, Yung WK, et al. Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model. PloS One. 2014;9(5):e97407. doi:10.1371/journal.pone.0097407. PMID:24827739.
   PubMed Web of Science ®Google Scholar
• Roman A, Munger K. The papillomavirus E7 proteins. Virology. 2013;445(1–2):138–68. doi:10.1016/j.virol.2013.04.013. PMID:23731972.
   PubMed Web of Science ®Google Scholar
• Phelps WC, Yee CL, Munger K, Howley PM. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell. 1988;53(4):539–47. doi:10.1016/0092-8674(88)90570-3. PMID:2836062.
   PubMed Web of Science ®Google Scholar
• Steinwaerder DS, Carlson CA, Lieber A. DNA replication of first-generation adenovirus vectors in tumor cells. Hum Gene Ther. 2000;11(13):1933–48. doi:10.1089/10430340050129549. PMID:10986565.
   PubMed Web of Science ®Google Scholar
• Steinwaerder DS, Carlson CA, Lieber A. Human papilloma virus E6 and E7 proteins support DNA replication of adenoviruses deleted for the E1A and E1B genes. Mol Ther: J Am Soc Gene Ther. 2001;4(3):211–6. doi:10.1006/mthe.2001.0447. PMID:11545611.
   PubMed Web of Science ®Google Scholar
• Yang Y, Luo Z, Qin Y, Zhou Y, Gong L, Huang J, Wang H. Production of bFGF monoclonal antibody and its inhibition of metastasis in Lewis lung carcinoma. Mol Med Rep. 2017;16(4):4015–4021. doi:10.3892/mmr.2017.7099.
   PubMed Web of Science ®Google Scholar
• Stankevicius V, Kuodyte K, Schveigert D, Bulotiene D, Paulauskas T, Daniunaite K, Suziedelis K. Gene and miRNA expression profiles of mouse Lewis lung carcinoma LLC1 cells following single or fractionated dose irradiation. Oncol Lett. 2017;13(6):4190–200. doi:10.3892/ol.2017.5877. PMID:28599420.
   PubMed Web of Science ®Google Scholar
• Gomez-Gutierrez JG, Nitz J, Sharma R, Wechman SL, Riedinger E, Martinez-Jaramillo E, Sam Zhou H, McMasters KM. Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo. Virology. 2016;487:249–59. doi:10.1016/j.virol.2015.10.019. PMID:26561948.
   PubMed Web of Science ®Google Scholar
• Rao XM, Tseng MT, Zheng X, Dong Y, Jamshidi-Parsian A, Thompson TC, Brenner MK, McMasters KM, Zhou HS. E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells. Cancer Gene Ther. 2004;11(9):585–93. doi:10.1038/sj.cgt.7700739. PMID:15338010.
   PubMed Web of Science ®Google Scholar
• Gomez-Gutierrez JG, Rao XM, Zhou HS, McMasters KM. Enhanced cancer cell killing by truncated E2F-1 used in combination with oncolytic adenovirus. Virology. 2012;433(2):538–547. doi:10.1016/j.virol.2012.09.003. PMID:23021422.
   PubMed Web of Science ®Google Scholar
• Gomez-Gutierrez JG, Rao XM, Garcia-Garcia A, Hao H, McMasters KM, Zhou HS. Developing adenoviral vectors encoding therapeutic genes toxic to host cells: comparing binary and single-inducible vectors expressing truncated E2F-1. Virology. 2010;397(2):337–45. doi:10.1016/j.virol.2009.11.021. PMID:20003994.
   PubMed Web of Science ®Google Scholar
• Wang LC, Lynn RC, Cheng G, Alexander E, Kapoor V, Moon EK, Sun J, Fridlender ZG, Isaacs SN, Thorne SH, et al. Treating tumors with a vaccinia virus expressing IFNbeta illustrates the complex relationships between oncolytic ability and immunogenicity. Mol Ther: J Am Soc Gene Ther. 2012;20(4):736–48. doi:10.1038/mt.2011.228. PMID:22008913.
   PubMed Web of Science ®Google Scholar
• Wang LC, Lynn RC, Cheng G, Alexander E, Kapoor V, Moon EK, Sun J, Fridlender ZG, Isaacs SN, Thorne SH, et al. Treating tumors with a vaccinia virus expressing IFNbeta illustrates the complex relationships between oncolytic ability and immunogenicity. Mol Ther: J Am Soc Gene Ther. 2012;20(4):736–48. doi:10.1038/mt.2011.228. PMID:22008913.
   PubMed Web of Science ®Google Scholar
• Di Paolo NC, Tuve S, Ni S, Hellstrom KE, Hellstrom I, Lieber A. Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses. Cancer Res. 2006;66(2):960–9. doi:10.1158/0008-5472.CAN-05-2388. PMID:16424031.
   PubMed Web of Science ®Google Scholar
• Hallden G, Hill R, Wang Y, Anand A, Liu TC, Lemoine NR, Francis J, Hawkins L, Kirn D. Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy. Mol Ther: J Am Soc Gene Ther. 2003;8(3):412–24. doi:10.1016/S1525-0016(03)00199-0. PMID:12946314.
   PubMed Web of Science ®Google Scholar